AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Gackenheimer, SL Schober, DA Gehlert, DR
Citation: Sl. Gackenheimer et al., Characterization of neuropeptide YY1-like and Y2-like receptor subtypes inthe mouse brain, PEPTIDES, 22(3), 2001, pp. 335-341

Authors: Gehlert, DR Yang, PY George, C Wang, Y Schober, D Gackenheimer, S Johnson, D Beavers, LS Gadski, RA Baez, M
Citation: Dr. Gehlert et al., Cloning and characterization of rhesus monkey neuropeptide Y receptor subtypes, PEPTIDES, 22(3), 2001, pp. 343-350

Authors: Schober, DA Gackenheimer, SL Heiman, ML Gehlert, DR
Citation: Da. Schober et al., Pharmacological characterization of I-125-1229U91 binding to Y1 and Y4 neuropeptide Y/peptide YY receptors, J PHARM EXP, 293(1), 2000, pp. 275-280

Authors: Sajdyk, TJ Gehlert, DR
Citation: Tj. Sajdyk et Dr. Gehlert, Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala, BRAIN RES, 877(2), 2000, pp. 226-234

Authors: Zarrinmayeh, H Zimmerman, DM Cantrell, BE Schober, DA Bruns, RF Gackenheimer, SL Ornstein, PL Hipskind, PA Britton, TC Gehlert, DR
Citation: H. Zarrinmayeh et al., Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists, BIOORG MED, 9(5), 1999, pp. 647-652

Authors: Britton, TC Spinazze, PG Hipskind, PA Zimmerman, DM Zarrinmayeh, H Schober, DA Gehlert, DR Bruns, RF
Citation: Tc. Britton et al., Structure-activity relationships of a series of benzothiophene-derived NPYY1 antagonists: Optimization of the C-2 side chain, BIOORG MED, 9(3), 1999, pp. 475-480

Authors: Morin, SM Ling, N Liu, XJ Kahl, SD Gehlert, DR
Citation: Sm. Morin et al., Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain, NEUROSCIENC, 92(1), 1999, pp. 281-291

Authors: Sajdyk, TJ Schober, DA Gehlert, DR Shekhar, A
Citation: Tj. Sajdyk et al., Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses, BEH BRA RES, 100(1-2), 1999, pp. 207-215

Authors: Gehlert, DR
Citation: Dr. Gehlert, Role of hypothalamic neuropeptide Y in feeding and obesity, NEUROPEPTID, 33(5), 1999, pp. 329-338

Authors: Siegel, MG Chaney, MO Bruns, RF Clay, MP Schober, DA Van Abbema, AM Johnson, DW Cantrell, BE Hahn, PJ Hunden, DC Gehlert, DR Zarrinmayeh, H Ornstein, PL Zimmerman, DM Koppel, GA
Citation: Mg. Siegel et al., Rapid parallel synthesis applied to the optimization of a series of potentnonpeptide neuropeptide Y-1 receptor antagonists, TETRAHEDRON, 55(39), 1999, pp. 11619-11639

Authors: Sajdyk, TJ Vandergriff, MG Gehlert, DR
Citation: Tj. Sajdyk et al., Amygdalar neuropeptide Y Y-1 receptors mediate the anxiolytic-like actionsof neuropeptide Y in the social interaction test, EUR J PHARM, 368(2-3), 1999, pp. 143-147

Authors: Ingenhoven, N Eckard, CP Gehlert, DR Beck-Sickinger, AG
Citation: N. Ingenhoven et al., Molecular characterization of the human neuropeptide YY2-receptor, BIOCHEM, 38(21), 1999, pp. 6897-6902
Risultati: 1-12 |